Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
American Heart Journal|July 7, 2024
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registryAnn Marie Navar, Nishant P Shah, Peter Shrader, et al.
The American Journal of Cardiology|August 16, 2005
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarctionEugenia Nikolsky, H Mehrdad Sadeghi, Mark B Effron, et al.
The American Journal of Cardiology|April 15, 2004
Final results of the ReoPro readministration registryJean-Pierre Dery, Gregory A Braden, A Michael Lincoff, et al.
JAMA Cardiology|July 10, 2024
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialCatherine P Benziger, Amanda Stebbins, Lisa M Wruck, et al.
Journal of the American Heart Association|June 22, 2023
Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE StudyRebecca Shen, Hillary Mulder, Lisa Wruck, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|August 7, 2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS StudyUsman Baber, Jaya Chandrasekhar, Samantha Sartori, et al.
European Heart Journal. Acute Cardiovascular Care|July 17, 2023
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS studyMauro Chiarito, Davide Cao, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 25, 2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS StudyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 15, 2019
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registryRishi Chandiramani, Huazhen Chen, Shunsuke Aoi, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
American Heart Journal|July 7, 2024
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registryAnn Marie Navar, Nishant P Shah, Peter Shrader, et al.
The American Journal of Cardiology|August 16, 2005
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarctionEugenia Nikolsky, H Mehrdad Sadeghi, Mark B Effron, et al.
The American Journal of Cardiology|April 15, 2004
Final results of the ReoPro readministration registryJean-Pierre Dery, Gregory A Braden, A Michael Lincoff, et al.
JAMA Cardiology|July 10, 2024
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialCatherine P Benziger, Amanda Stebbins, Lisa M Wruck, et al.
Journal of the American Heart Association|June 22, 2023
Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE StudyRebecca Shen, Hillary Mulder, Lisa Wruck, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
JACC. Cardiovascular Interventions|August 7, 2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS StudyUsman Baber, Jaya Chandrasekhar, Samantha Sartori, et al.
European Heart Journal. Acute Cardiovascular Care|July 17, 2023
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS studyMauro Chiarito, Davide Cao, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 25, 2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS StudyJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 15, 2019
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registryRishi Chandiramani, Huazhen Chen, Shunsuke Aoi, et al.
Pageof 10